Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Subsequent therapies in ≥2% of patients in either arm
| Subsequent therapies, n (%) | Dacarbazine (n=338) | Vemurafenib (n=337) |
|---|---|---|
| Any subsequent anticancer therapy | 173 (51) | 175 (52) |
| Ipilimumab | 88 (26) | 93 (28) |
| Dacarbazine/temozolomide | 28 (8) | 64 (20) |
| Vemurafeniba | 39 (12) | 23 (7) |
| Other chemotherapy | 46 (14) | 24 (7) |
| Dabrafenib | 7 (2) | 7 (2) |
| BRAF inhibitor NOS | 13 (4) | 1 (<1) |
| Trametinib | 7 (2) | 5 (2) |
Commercially available vemurafenib or expanded access.
NOS, not otherwise specified.
